New Molecules and Indications for GLP-1 Medicines
María J. Gonzalez-Rellan, Daniel J. Drucker
Abstract
This Perspective explores recent progress and future directions in glucagon-like peptide-1 medicines.
Topics & Concepts
MedicinePerspective (graphical)PharmacologyMEDLINEIntensive care medicineSmall moleculeDrug approvalComputational biologyDrug industryEngineering ethicsDiabetes Treatment and ManagementPharmacology and Obesity TreatmentNatural Antidiabetic Agents Studies